Erythropoietic Protoporphyria: Diagnosis, Treatment and Care

Imagine being unable to step outside without experiencing severe, burning pain in your skin within minutes. This is the reality for people with erythropoietic protoporphyria, a rare metabolic disorder that makes sun exposure not just uncomfortable but debilitating.

Erythropoietic protoporphyria (EPP) is a rare inherited metabolic disorder that affects the production of heme, an essential component of red blood cells. A buildup of protoporphyrin IX in the blood leads to severe photosensitivity, causing painful skin reactions after even minimal sun exposure.

This article provides a comprehensive guide to understanding EPP's causes, symptoms, diagnostic methods, and treatment strategies.

[signup]

What is Erythropoietic Protoporphyria?

To understand erythropoietic protoporphyria (EPP), it helps to first learn about heme and its importance for the body.

Erythropoietic Protoporphyria (EPP) is a rare genetic disorder that disrupts the normal production of heme.  Heme is a protein in red blood cells that carries oxygen to different parts of the body. It also gives blood its red color. 

In EPP, the body does not produce enough of an enzyme called ferrochelatase, which is needed for the last step of making heme. Because of this, a substance called protoporphyrin IX builds up in the blood and skin instead of being converted into heme. When protoporphyrin IX is exposed to sunlight, it absorbs light energy and damages the skin, leading to pain, swelling, and redness. 

Classification within Porphyrias

Porphyrias are divided into acute and cutaneous types:

• Acute porphyrias: Affects the nervous system and causes severe pain, vomiting, and neurological symptoms.
• Cutaneous porphyrias: Lead to skin sensitivity and blistering, with EPP being a non-blistering subtype.

Prevalence 

EPP is rare, with an estimated prevalence of 1 in 75,000 to 200,000 people worldwide. It is more common in Asians than in White or Black people.  

Causes of Erythropoietic Protoporphyria

EPP is primarily genetic, but environmental and rare factors can also influence its severity.

Genetic Factors and Inheritance Patterns

• Mutations in the FECH gene (ferrochelatase) are the most common cause of EPP.
• Inheritance follows an autosomal recessive or dominant pattern with incomplete penetrance, meaning some people may have the mutation but experience mild or no symptoms.
• Sunlight is the biggest trigger for EPP symptoms. When people with EPP go out in the sun, a substance in their blood called protoporphyrin IX absorbs light and causes pain, redness, and swelling in their skin.
• Certain medications, such as estrogen-based medications and certain antibiotics (e.g., rifampicin, sulfonamides), may interfere with heme metabolism and could potentially worsen symptoms in some individuals. Patients should consult their doctor before taking new medications.

Rare Causes and Genetic Mutations

• X-linked Protoporphyria (XLP) is a condition similar to EPP but often more severe. It is caused by a mutation in the ALAS2 gene and is passed down through the X chromosome, meaning it mostly affects males.
• People with XLP may develop symptoms earlier in life and may have a higher risk of liver problems than those with EPP.

Pathophysiology of EPP

EPP is caused by a defect in heme production, leading to the accumulation of protoporphyrin IX in red blood cells, plasma, and the liver. While protoporphyrin buildup occurs in all EPP patients, only a subset experience liver complications due to varying levels of accumulation and other risk factors.

Hemoglobin Synthesis Disruption

• Heme is an essential component of hemoglobin, which carries oxygen in the blood.
• In EPP, ferrochelatase enzyme activity is reduced, preventing the conversion of protoporphyrin IX into heme.

Accumulation of Protoporphyrin

• Excess protoporphyrin accumulates in tissues and circulates in the bloodstream.
• When exposed to light, it generates reactive oxygen species (ROS), causing inflammation and tissue damage.

Symptoms and Diagnosis

Erythropoietic Protoporphyria (EPP) mainly affects the skin, causing severe pain after sun exposure. However, in some cases, systemic complications such as gallstones or liver problems may develop.

Recognizing the Symptoms of EPP

Acute Photosensitivity Reactions

The most noticeable symptom of EPP is severe pain after sun exposure, though the intensity and duration of pain can vary between individuals. Unlike sunburn, this pain:

• Starts within minutes to hours of sunlight exposure.
• Causes intense burning, redness, and swelling, but no blisters.
• It can last for hours or even days, making it difficult to do daily activities outside.
• Often forces patients to avoid sunlight and bright indoor lighting.

Chronic Skin Issues

Over time, repeated sun exposure can cause lasting changes to the skin, even with protective measures. Some common long-term effects include:

• Thickened or leathery skin in areas frequently exposed to sunlight.
• Small scars or waxy patches, especially on the knuckles, nose, or cheeks.
• The skin may become more fragile and prone to damage in rare cases.

Systemic Complications

Although EPP primarily affects the skin, protoporphyrin IX can also build up in the liver, leading to complications such as:

• Gallstones: Because protoporphyrin is excreted through bile, high levels can increase the risk of gallstone formation.
• Liver Dysfunction or Liver Failure: In about 5-10% of patients, excessive protoporphyrin damages the liver, leading to scarring (fibrosis) or liver failure.

Diagnostic Procedures

The first step towards diagnosis involves a thorough clinical evaluation and medical history.  Healthcare providers assess symptom patterns, focusing on painful, non-blistering photosensitivity.

Laboratory Tests and Biomarkers

Blood tests can help confirm EPP by measuring the levels of protoporphyrin IX in the body:

• Plasma Protoporphyrin Levels: EPP patients have elevated free protoporphyrin IX, which does not dissolve in water and builds up in red blood cells.
• Liver Function Tests (LFTs): Since protoporphyrin can accumulate in the liver, these tests help monitor early signs of liver damage.

Genetic Testing 

• Genetic testing that shows FECH or ALAS2 gene mutations confirms the diagnosis.
• Helps identify carriers and family risk factors.

Treatment and Management

While there is no cure for EPP, management focuses on protecting the skin from sunlight, managing symptoms, and preventing complications, particularly those affecting the liver. 

Photoprotection Strategies

Since sunlight is the main trigger for symptoms, the best way to manage EPP is to limit sun exposure and protect the skin as much as possible:

• Avoid direct sunlight, especially during peak daylight hours.
• Wear protective clothing, including long sleeves, wide-brimmed hats, gloves, and sunglasses.
• Using tinted or UV-blocking windows in homes, cars, and workplaces filters out harmful light.
• Some studies suggest that beta-carotene supplements may help improve skin tolerance to sunlight for certain individuals, but effectiveness varies.

Medications and Supplements

Certain medications can help reduce symptoms and improve sun tolerance:

• Afamelanotide (Scenesse®): This is currently the only FDA-approved drug for EPP. It has been shown to increase tolerance to sunlight in some patients, but individual responses may vary. 
• Pain relievers and anti-inflammatory medications can help manage discomfort from sun exposure but do not prevent symptoms.

Managing Acute Flares

The following may help reduce painful reactions after sun exposure:

• Applying cold compresses to the affected areas to soothe burning and swelling.
• Taking anti-inflammatory pain relievers, such as ibuprofen, to ease discomfort.
• Staying in a dark, cool environment to prevent symptoms from worsening.

Integrative and Functional Approaches

Many patients explore lifestyle and dietary changes to help manage symptoms and prevent complications. While integrative approaches do not replace medical treatments, they can provide additional support.

Dietary Modifications

• Since protoporphyrin IX is excreted through bile, some experts suggest that a low-fat diet may help reduce gallstone formation in some individuals, though further research is needed.
• Taking vitamin D supplements is important for bone health as EPP patients often avoid sunlight, which is needed to produce vitamin D naturally.

Alternative Therapies

Some patients explore antioxidants like vitamins C and E, which may help reduce oxidative stress and support overall health. Still, there is limited clinical evidence supporting their effectiveness in EPP management.

Lifestyle Adjustments for Better Management

• Using red-filtered indoor lighting can help prevent symptoms triggered by artificial light sources.
• Plan outdoor activities carefully, such as going outside early in the morning or evening when the sun is less intense.
• Educating friends, family, and employers about EPP to help create a more accommodating environment.

Complications and Long-Term Outlook

Although EPP mainly affects the skin, long-term complications can develop, particularly in the liver. 

Potential Complications of EPP

Most people with EPP can manage their symptoms by avoiding sunlight, and following treatment recommendations, but in some cases, serious complications can develop.

Liver Involvement

While most EPP patients do not develop severe liver disease, a small percentage experience liver dysfunction, which can lead to liver failure in rare cases. In severe cases, a liver transplant may be necessary. However, even after a transplant, EPP can still affect the new liver, so careful monitoring is required.

Risk of Skin Cancer and Bone Health Issues

People with EPP often avoid the sun altogether, which can lead to low vitamin D levels.

• Vitamin D is important for strong bones and immune system function, so that long-term deficiency may increase the risk of osteoporosis (weakened bones) and other health issues.
• Some studies suggest that chronic sun avoidance and low vitamin D levels may slightly increase the risk of skin cancer, although more research is needed.
• Taking vitamin D supplements and spending short periods in indirect sunlight (such as near shaded areas or windows with UV protection) can help maintain healthy vitamin D levels.

Prognosis and Future Outlook

While EPP remains a lifelong condition, new advancements in medicine and technology offer hope for better management and improved quality of life for patients in the future.

• Scientists are exploring gene therapy as a potential cure for EPP by correcting the faulty FECH gene.
• Experimental treatments aim to increase ferrochelatase enzyme activity, which could help reduce protoporphyrin buildup and symptoms.

Ongoing clinical trials are testing new drugs to improve photoprotection and allow patients to spend more time outdoors safely.

[signup]

Key Takeaways

• Erythropoietic protoporphyria (EPP) is a rare genetic disorder that affects heme production. It leads to a buildup of protoporphyrin IX, which causes severe skin pain and sensitivity to sunlight.
• Symptoms appear within minutes of sun exposure, causing burning pain, redness, and swelling, but unlike other porphyrias, there are no blisters.
• EPP can lead to long-term complications, including liver damage (in 5-10% of cases) and gallstones due to the buildup of protoporphyrin IX in the liver.
• Diagnosis is based on clinical symptoms, laboratory tests, and genetic testing, which helps confirm FECH gene mutations and identify at-risk family members.
• There is no cure for EPP, but treatments focus on photoprotection, symptom management, and liver health, including sun avoidance, protective clothing, and FDA-approved medications like Afamelanotide (Scenesse®).
• Vitamin D deficiency is a concern for many EPP patients due to strict sun avoidance, increasing the risk of bone health problems and other deficiencies.
• Researchers are exploring gene therapy and new medications to improve photoprotection and reduce symptoms, offering hope for better treatments in the future.
• With the right management strategies, lifestyle adjustments, and emerging treatments, individuals with EPP can improve their quality of life and reduce the risk of complications.